From the beginning of the covid-19 pandemic, we have already tested approx. 2,500 patients as part of various research projects.

Despite the ongoing Covid-19 pandemic at the BRG facility, we are still active and with ongoing projects. We maintain constant contact with our patients who are open to participation in new research. In order to maintain appropriate prophylaxis and safety of the conducted projects we perform according to the highest standards, using instructions and procedures of the Ministry of Health, Sanitary-epidemiological station, WHO (World Health Organization) and EMA (European Medicines Agency).

We have already tested approximately 2,500 patients as part of various research projects. The safety of patients is supervised by qualified nurses, laboratory technicians, pharmacists and coordinators as well as recognized medical experts with many years of experience and knowledge. This confirm that our site is effective and efficient and able to provide rapid study start-up for trials research of various therapies even in challenging environment.

Go back

News

Open Recruitment to new study

We have started new study with testosterone for healthy Volunteers or Patients with testosterone deficiency.

Read more …

FIM study

We have just succesfully finished First in Man study with psychoactive substance.

Read more …

Christmas wishes

To all our Sponsors, partners, subcontractors and co-workers we would like to wish joyful Christmas and a Happy New Year!

Read more …

Participation in NCBiR project

As a Clinical Site we have won a tender for an innovative 1st phase project co-funded by NCBiR.

Read more …

GMP Specialist

Ms Dorota Osińska, M.Sc., Pharmacist, QP and experienced auditor, joined BioResearch and started GMP certification process.

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2022 © Bio Research Group. All rights reserved.

 

scroll to top ▲